Fig. 3From: Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapyT1-weighted MRI in June of 2016 showing bulky tumor recurrence (red arrows) in axial and coronal planeBack to article page